NEI
CGON icon

Northwest & Ethical Investments’s CG Oncology CGON Stock Holding History

Northwest & Ethical Investments’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$212K Buy
+3,140
New +$178K ﹤0.01% 483

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Northwest & Ethical Investments's CGON Position: Q1 2026 in Review

Northwest & Ethical Investments opened a new position in CG Oncology (CGON) in Q1 2026: 3,140 shares worth $212K. The stake represents ﹤0.01% of the portfolio and ranks #483 among its holdings.

233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Northwest & Ethical Investments held 3,140 shares of CG Oncology worth $212K as of Q1 2026.
  • CG Oncology was a new Northwest & Ethical Investments position in Q1 2026.
  • CG Oncology made up ﹤0.01% of Northwest & Ethical Investments's portfolio in Q1 2026, its #483 holding.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Northwest & Ethical Investments's 13F filing for Q1 2026, filed 14 May 2026.